Immunocore Holdings plc Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 36.48M174.36M249.43M310.20M
Cost of Revenue 1.09M1.04M2.73M
Gross Profit 36.48M173.27M248.39M307.47M
Operating items
Research & Development 100.25M101.92M163.54M222.15M
Selling, General & Administrative 110.82M123.06M144.50M155.78M
Operating Expenses 211.07M224.98M308.04M377.93M
Operating Income -174.59M-51.71M-59.65M-70.46M
EBIT -174.59M-51.71M-59.65M-70.46M
Non-operating items
Interest & Investment Income 0.07M3.76M17.99M25.62M
Other Non Operating Income 0.29M14.16M-13.18M14.20M
Non Operating Income -0.07M-1.68M-0.90M14.20M
Net income details
EBT -179.88M-40.88M-60.89M-52.94M
Tax Provisions -0.24M11.66M-5.60M-1.85M
Profit After Tax -180.03M-52.54M-55.29M-51.09M
Income from Continuing Operations -179.64M-52.54M-55.29M-51.09M
Consolidated Net Income -179.64M-52.54M-55.29M-51.09M
Income towards Parent Company -179.64M-52.54M-55.29M-51.09M
Net Income towards Common Stockholders -179.64M-52.54M-55.29M-51.09M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 40.74M40.74M43.86M47.90M49.44M50.03M
Shares Outstanding (Diluted Average) 48.89M49.99M
EBITDA -180.28M-76.90M-36.88M-48.59M
Tax Rate 0.14%9.20%3.49%